Eastman Chemical EVP files Form 3; 60,301 direct shares
Eastman Chemical (EMN) executive Stephen G. Crawford, EVP, Technology Projects, filed an initial statement of beneficial ownership.
Rhea-AI Filing Summary
Eastman Chemical (EMN) executive Stephen G. Crawford, EVP, Technology Projects, filed an initial statement of beneficial ownership. He reports 60,301 shares of common stock held directly, plus indirect holdings through retirement plans and spouse accounts.
He also lists employee stock options covering multiple grants, including 24,527 shares at $86.15 expiring 02/26/2034 and 25,883 shares at $83.84 expiring 02/23/2033. Vesting schedules note one‑third becoming exercisable on specified dates in 2025–2027 for recent grants.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. One-third of the option became exercisable on each of February 27, 2025, and one-third of the option becomes exercisable on each of February 27, 2026, and February 27, 2027.
- F2. One-third of the option became exercisable on each of February 24, 2024, and February 24, 2025, and one-third becomes exercisable on February 24, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did EMN disclose in this filing?
Who is the reporting person for EMN?
What indirect EMN holdings are reported?
What key EMN option positions are disclosed?
What are the vesting terms mentioned?
What is the event date for this insider report?
AI-generated analysis. How Rhea-AI works. Not financial advice.